Electrical and pharmacologic cardioversion for atrial fibrillation.
This article describes electrical and pharmacologic cardioversion for atrial fibrillation and discusses indications for cardioversion and management of pericardioversion anticoagulation. Finally, management strategies are offered for immediate recurrence of atrial fibrillation and cardioversion failure.
Kim
Susan S
SS
Section of Cardiology, Department of Medicine, University of Chicago Medical Center, 5758 South Maryland Avenue MC9024, Chicago, IL 60637, USA.
Knight
Bradley P
BP
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006328:Cardiac Catheterization / Q000295:instrumentation / Q000379:methods; D047548:Defibrillators; D004554:Electric Countershock / Q000295:instrumentation / Q000379:methods*; D004867:Equipment Design; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants